Sandy Balkin

SVP Strategy and Analytics

Royalty Pharma

SVP of Strategy and Analytics at Royalty Pharma leading the development of strategic data science and real-world evidence initiatives. Our team's commitment to rigorous opportunity assessment is pivotal in fostering innovation within the life sciences sector. We have been instrumental in expanding the company's footprint by implementing advanced analytical methodologies that drive strategic investments.

Chair of the Mount Sinai - Royalty Pharma Alliance for Health Equity Research Steering Committee, leveraging corporate strategy expertise to address health disparities and Adjunct lecturer in Columbia University's Applied Analytics program.